TickerFacts.

Opus Genetics, Inc. (IRD): Shares Outstanding

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2019-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

69.89M
As of 2025-12-31
82.65M
As of 2026-06-30
+49.6%
3-year compound annual growth
+45.1%
5-year compound annual growth
197.41M2010-12-31: 84.16M2011-12-31: 95.35M2012-12-31: 119.43M2013-12-31: 146.72M2014-12-31: 178.25M2015-12-31: 197.41M2016-12-31: 23.74M2017-12-31: 31.73M2018-12-31: 3.12M2019-12-31: 2.85M2020-12-31: 10.88M2021-12-31: 18.85M2022-12-31: 20.86M2023-12-31: 23.98M2024-12-31: 31.57M2025-12-31: 69.89M69.89M
2010-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-3169.89M+121.4%2026-03-12, Balance as of period end
2024-12-3131.57M+31.7%2026-03-12, Balance as of period end
2023-12-3123.98M+14.9%2025-03-31, Balance as of period end
2022-12-3120.86M+10.7%2024-03-08, Balance as of period end
2021-12-3118.85M+73.2%2023-03-30, Balance as of period end
2020-12-3110.88Mn/c2022-03-24, Balance as of period end
2019-12-312.85Mn/c2021-03-11, Balance as of period end
2018-12-313.12Mn/c2020-02-21, Balance as of period end
2017-12-3131.73M+33.7%2019-03-07, Balance as of period end
2016-12-3123.74M-88.0%2018-03-09, Balance as of period end
2015-12-31197.41M+10.7%2017-02-24, Balance as of period end
2014-12-31178.25M+21.5%2016-03-14, Balance as of period end
2013-12-31146.72M+22.8%2015-03-16, Balance as of period end
2012-12-31119.43M+25.3%2014-03-21, Balance as of period end
2011-12-3195.35M+13.3%2013-03-22, Balance as of period end
2010-12-3184.16Mn/a2012-03-16, Balance as of period end